Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument

被引:57
作者
Khanna, Dinesh
Hays, Ron D.
Park, Grace S.
Braun-Moscovici, Yolanda
Mayes, Maureen D.
McNearney, Terry A.
Hsu, Vivien
Clements, Philip J.
Furst, Daniel E.
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA
[2] Univ Cincinnati, Vet Affairs Med Ctr, Cincinnati, OH USA
[3] RAND Corp, Santa Monica, CA USA
[4] Rambam Med Ctr, Haifa, Israel
[5] Univ Texas, Houston, TX USA
[6] Univ Texas, Galveston, TX 77555 USA
[7] Univ Med & Dent New Jersey, New Brunswick, NJ USA
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2007年 / 57卷 / 07期
关键词
scleroderma; gastrointestinal tract; health-related quality of life instrument; questionnaire;
D O I
10.1002/art.22987
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Gastrointestinal tract (GIT) involvement occurs in similar to 90% of patients with systemic sclerosis (SSc) and has a major impact on health-related quality of life (HRQOL). We developed an HRQOL instrument for persons with SSc. Methods. The Scleroderma Gastrointestinal Tract 1.0 (SSC-GIT 1.0) survey was developed after an extensive literature search, solicitation and consideration of experts' opinions, and 2 focus groups of 16 subjects with SSc and GIT involvement. A 75-item, self-reported measure assessing bowel involvement, emotional well-being, and social functioning was administered to subjects with SSc and GIT involvement. Also, subjects completed the Short Form 36 and rated the severity of their GIT symptoms (very mild to very severe), and items were transformed linearly to a scale with a possible range of 0 (worse health) to 100 (better health). Evaluation of psychometric properties included internal consistency reliability, test-retest reliability (1.3-week median time interval), multitrait scaling analysis, and exploratory factor analysis. Results. Study participants (n = 88) were primarily female (95.5%), white (79.3%), and had a mean age of 52.4 years. Self-rated severity of GIT involvement ranged from very mild or mild (36.0%) to moderate (44.0%) to severe or very severe (20.0%). Of 75 items, 23 had low item-total correlations (<= 0.39) and were excluded, leaving a 52-item instrument. Analyses supported 6 multi-item HRQOL scales: reflux/indigestion, diarrhea, constipation, pain, emotional well-being, and social functioning. Test-retest reliability estimates ranged 0.69-0.90 and Cronbach's alpha ranged 0.69-0.93. Participants who rated their GIT disease as mild had the highest scores (better health) on all 6 scales; participants who rated their GIT as severe had the lowest scores (poor health). Conclusion. The results support the reliability and validity of the SSC-GIT 1.0 as a measure of SSc GIT involvement. Further research is needed to examine the ability to detect change over time and define minimally important differences.
引用
收藏
页码:1280 / 1286
页数:7
相关论文
共 34 条
[1]  
BEST WR, 1976, GASTROENTEROLOGY, V70, P439
[2]   Systemic sclerosis: hypothesis-driven treatment strategies [J].
Charles, Christina ;
Clements, Philip ;
Furst, Daniel E. .
LANCET, 2006, 367 (9523) :1683-1691
[3]   Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients [J].
Cole, Jason C. ;
Khanna, Dinesh ;
Clements, Philip J. ;
Seibold, James R. ;
Tashkin, Donald P. ;
Paulus, Harold E. ;
Irwin, Michael R. ;
Motivala, Sarosh J. ;
Furst, Daniel E. .
QUALITY OF LIFE RESEARCH, 2006, 15 (08) :1383-1394
[4]  
CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297, DOI DOI 10.1007/BF02310555
[5]   Factor analysis in the development and refinement of clinical assessment instruments [J].
Floyd, FJ ;
Widaman, KF .
PSYCHOLOGICAL ASSESSMENT, 1995, 7 (03) :286-299
[6]   MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS [J].
FRIES, JF ;
SPITZ, P ;
KRAINES, RG ;
HOLMAN, HR .
ARTHRITIS AND RHEUMATISM, 1980, 23 (02) :137-145
[7]  
Furst DE, 2005, J RHEUMATOL, V32, P2477
[8]   Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis [J].
Gliddon, Angela E. ;
Dore, Caroline J. ;
Maddison, Peter J. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (03) :473-479
[9]  
Groll D, 2002, AM J GASTROENTEROL, V97, P962
[10]   A NEW MEASURE OF HEALTH-STATUS FOR CLINICAL-TRIALS IN INFLAMMATORY BOWEL-DISEASE [J].
GUYATT, G ;
MITCHELL, A ;
IRVINE, EJ ;
SINGER, J ;
WILLIAMS, N ;
GOODACRE, R ;
TOMPKINS, C .
GASTROENTEROLOGY, 1989, 96 (03) :804-810